Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
DATA GRAPHICS | Data Byte

Translational spotlight on immuno-oncology innovation

Mechanisms in BioCentury’s Distillery extend beyond checkpoints

June 7, 2023 10:51 PM UTC

Immuno-oncology innovations published by academics over the last year include non-checkpoint targets that modulate T cell killing thresholds, and strategies to decrease immunosuppressive conditions in the tumor microenvironment.

Save for a few bright spots, industry momentum in immuno-oncology has shown signs of slowing down, but academic investigators are still discovering new targets and agents to drive antitumor immunity...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article